Literature DB >> 30247200

Contribution of Loss of Large Fiber Function to Pain in 2 Samples of Oncology Patients.

Christine Miaskowski1, Steven M Paul1, Judy Mastick1, Gary Abrams2, Kimberly Topp2, Betty Smoot2, Kord M Kober1, Margaret Chesney2, Mark Schumacher2, Yvette P Conley3, Marilyn Hammer4, Steven Cheung2, David Borsook5,6, Jon D Levine2,7.   

Abstract

OBJECTIVES: Numbness associated with neuropathic pain suggests the loss of function in myelinated, large diameter sensory neurons. The purpose of this study was to examine the relationships between pain severity and subjective (ie, severity of numbness) and objective (ie, loss of light touch sensations, vibration thresholds) measures of loss of large fiber function in adult survivors with chemotherapy-induced peripheral neuropathy (CIPN, n=426) and breast cancer patients with persistent postsurgical pain (n=80).
MATERIAL AND METHODS: For both samples, average pain and numbness were evaluated using a 0 to 10 numeric rating scale. Loss of light touch sensations in the hands and feet of patients with CIPN and in the upper arm of patients at 5 and 6 months following breast cancer surgery were assessed using Semmes Weinstein monofilaments. Loss of vibration in the hands and feet of patients with CIPN was assessed using a biothesiometer. Pearson Product Moment correlation coefficients were calculated between average pain and the number or percentage of sites with loss of light touch sensations, mean vibration thresholds, and the severity of numbness.
RESULTS: For both pain conditions, average pain scores were significantly correlated with objective measures of large fiber function (r=0.12 to 0.34; all P<0.05) and numbness (r=0.22 to 0.52; all P<0.008). DISCUSSION: Our findings, in 2 independent samples of oncology patients, suggest that loss of function of myelinated, large diameter fibers contributes to the severity of neuropathic pain.

Entities:  

Year:  2019        PMID: 30247200      PMCID: PMC6309865          DOI: 10.1097/AJP.0000000000000649

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  42 in total

1.  Post-axillary dissection pain in breast cancer due to a lesion of the intercostobrachial nerve.

Authors:  C J Vecht; H J Van de Brand; O J Wajer
Journal:  Pain       Date:  1989-08       Impact factor: 6.961

2.  Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: a randomized trial.

Authors:  Kenneth Geving Andersen; Rune Gärtner; Niels Kroman; Henrik Flyger; Henrik Kehlet
Journal:  Breast       Date:  2011-08-23       Impact factor: 4.380

3.  Chronic Pain and Neuropathy Following Adjuvant Chemotherapy.

Authors:  Lise Ventzel; Caspar S Madsen; Páll Karlsson; Hatice Tankisi; Baris Isak; Anders Fuglsang-Frederiksen; Anders B Jensen; Anni R Jensen; Troels S Jensen; Nanna B Finnerup
Journal:  Pain Med       Date:  2018-09-01       Impact factor: 3.750

4.  Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat.

Authors:  K D Cliffer; J A Siuciak; S R Carson; H E Radley; J S Park; D R Lewis; E Zlotchenko; T Nguyen; K Garcia; J R Tonra; N Stambler; J M Cedarbaum; S C Bodine; R M Lindsay; P S DiStefano
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

Review 5.  Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults.

Authors:  William Gibson; Benedict M Wand; Neil E O'Connell
Journal:  Cochrane Database Syst Rev       Date:  2017-09-14

Review 6.  Radiation-induced neuropathy in cancer survivors.

Authors:  Sylvie Delanian; Jean-Louis Lefaix; Pierre-François Pradat
Journal:  Radiother Oncol       Date:  2012-12       Impact factor: 6.280

7.  Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Raimond Wong; Pierre Major; Stephen Sagar
Journal:  Integr Cancer Ther       Date:  2016-04-29       Impact factor: 3.279

8.  Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; Breanna L Weisbrod; Drew K Seisler; Debra L Barton; Kelliann C Fee-Schroeder; Thomas J Smith; Daniel H Lachance; Heshan Liu; Randy A Shelerud; Andrea L Cheville; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

9.  Scrambler Therapy for the Treatment of Chronic Post-Mastectomy Pain (cPMP).

Authors:  Thomas Smith; Andrea L Cheville; Charles L Loprinzi; Denise Longo-Schoberlein
Journal:  Cureus       Date:  2017-06-21

Review 10.  A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Yusuke Fukuda; Yihang Li; Rosalind A Segal
Journal:  Front Neurosci       Date:  2017-08-31       Impact factor: 4.677

View more
  1 in total

1.  Mapping chemotherapy-induced peripheral neuropathy phenotype and health-related quality of life in patients with cancer through exploratory analysis of multimodal assessment data.

Authors:  Mian Wang; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2022-01-21       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.